Spike And Nucleocapsid Protein Mutations In Tanzanian And Ugandan Strains Of SARS-CoV-2 Demand Attention

We analyze a new paper by Arora et al. that compares the ability of one of these strains, A.30, which contains a highly mutated S protein, to avoid neutralization by antibodies derived from convalescent sera, monoclonal antibody treatment, or vaccine.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive